With the firm's products under development referred to as "hematically modified RNA origami-based anticoagulant and reversal agent"., the principals of the firm describe their business development objective as that of becoming leaders at the forefront of a paradigm shift in pharmaceuticals for better human health The firm's technology utilizes RNA-origami -- decorated and functionalized with aptamers. A simple analogy is noted as being that of thinking of the RNA-origami as the palm of a hand and the aptamers as fingers attached to the palm. Using RNA in a way that is referenced as "different to others' Helixomer does not encode anything into the genome. Instead, the approach is to use RNA for its structural properties. It is also noted that RNA-origami is similar to paper origami except that it self-assembles into the three dimensional shape with consistency that is readily scalable.
